Loss of Y in leukocytes as a risk factor for critical COVID-19 in men
Authors:
- Bożena Bruhn-OlszewskaBożena Bruhn-Olszewska
- Hanna DaviesHDHanna Davies
- Daniil SarkisyanDaniil Sarkisyan
- Ulana JuhasUlana Juhas
- Edyta Rychlicka-BuniowskaEdyta Rychlicka-Buniowska
- Magdalena WójcikMWMagdalena Wójcik
- Monika HorbaczMHMonika Horbacz
- Marcin JąkalskiMarcin Jąkalski
- Paweł OlszewskiPaweł Olszewski
- Jakub O. WestholmJakub O. Westholm
- Karol WierzbaKarol Wierzba
Open Access
- 14 December 2022
- journal article
- research article
- Published by Springer Nature in Genome Medicine
- Vol. 14 (1) , 1-14
Abstract
Background: The COVID-19 pandemic, which has a prominent social and economic impact worldwide, shows a largely unexplained male bias for the severity and mortality of the disease. Loss of chromosome Y (LOY) is a risk factor candidate in COVID-19 due to its prior association with many chronic age-related diseases, and its impact on immune gene transcription.Methods: Publicly available scRNA-seq data of PBMC samples derived from male patients critically ill with COVID-19 were reanalyzed, and LOY status was added to the annotated cells. We further studied LOY in whole blood for 211 COVID-19 patients treated at intensive care units (ICU) from the first and second waves of the pandemic. Of these, 139 patients were subject to cell sorting for LOY analysis in granulocytes, low-density neutrophils (LDNs), monocytes, and PBMCs.Results: Reanalysis of available scRNA-seq data revealed LDNs and monocytes as the cell types most affected by LOY. Subsequently, DNA analysis indicated that 46%, 32%, and 29% of critically ill patients showed LOY above 5% cut-off in LDNs, granulocytes, and monocytes, respectively. Hence, the myeloid lineage that is crucial for the development of severe COVID-19 phenotype is affected by LOY. Moreover, LOY correlated with increasing WHO score (median difference 1.59%, 95% HDI 0.46% to 2.71%,p=0.025), death during ICU treatment (median difference 1.46%, 95% HDI 0.47% to 2.43%,p=0.0036), and history of vessel disease (median difference 2.16%, 95% HDI 0.74% to 3.7%,p=0.004), among other variables. In 16 recovered patients, sampled during ICU stay and 93–143 days later, LOY decreased significantly in whole blood and PBMCs. Furthermore, the number of LDNs at the recovery stage decreased dramatically (median difference 76.4 per 10,000 cell sorting events, 95% HDI 55.5 to 104,p=6e−11).Conclusions: We present a link between LOY and an acute, life-threatening infectious disease. Furthermore, this study highlights LOY as the most prominent clonal mutation affecting the myeloid cell lineage during emergency myelopoiesis. The correlation between LOY level and COVID-19 severity might suggest that this mutation affects the functions of monocytes and neutrophils, which could have consequences for male innate immunity.Keywords
All Related Versions
Funding Information
- Uppsala University
This publication has 50 references indexed in Scilit:
- Mosaic Loss of Chromosome Y in Blood Is Associated with Alzheimer DiseaseThe American Journal of Human Genetics, 2016
- New data shed light on Y‐loss‐related pathogenesis in myelodysplastic syndromesGenes, Chromosomes and Cancer, 2015
- Smoking is associated with mosaic loss of chromosome YScience, 2015
- Age-Related Clonal Hematopoiesis Associated with Adverse OutcomesNew England Journal of Medicine, 2014
- The pattern of Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive epidemiological analysis of data from the Saudi Ministry of HealthInternational Journal of General Medicine, 2014
- Mosaic loss of chromosome Y in peripheral blood is associated with shorter survival and higher risk of cancerNature Genetics, 2014
- Y chromosome loss in male patients with primary biliary cirrhosisJournal of Autoimmunity, 2013
- Increased loss of the Y chromosome in peripheral blood cells in male patients with autoimmune thyroiditisJournal of Autoimmunity, 2012
- Sex- and Age-Related Differences in Morbidity Rates of 2009 Pandemic Influenza A H1N1 Virus of Swine Origin in JapanPLOS ONE, 2011
- Do Men Have a Higher Case Fatality Rate of Severe Acute Respiratory Syndrome than Women Do?American Journal of Epidemiology, 2004